The Pain in Neuropathy Study (PiNS): A cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy

Pain

Volumn 157, Issue 5, 2016, Pages 1132-1145

  Themistocleous, Andreas C ^a   Ramirez, Juan D ^a   Shillo, Pallai R ^b   Lees, Jonathan G ^c   Selvarajah, Dinesh ^b   Orengo, Christine ^c   Tesfaye, Solomon ^b   Rice, Andrew S C ^d,e   Bennett, David L H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic pain; Diabetes; Diabetic neuropathy; Neuropathic pain; Quantitative sensory testing

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CODEINE; DULOXETINE; FENTANYL; GABAPENTIN; IMIPRAMINE; LIDOCAINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PARACETAMOL; PREGABALIN; TRAMADOL;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE CONDUCTION; NERVE FIBER DENSITY; NERVOUS SYSTEM PARAMETERS; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PAIN INTENSITY; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SOMATOSENSORY SYSTEM; CLINICAL TRIAL; COMPLICATION; ELECTROSTIMULATION; INNERVATION; MIDDLE AGED; NERVE FIBER; NEURALGIA; NEUROLOGIC EXAMINATION; PATHOLOGY; PHYSIOLOGY; SENSATION; SEVERITY OF ILLNESS INDEX; SKIN;

AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEUROPATHIES; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; NEURAL CONDUCTION; NEURALGIA; NEUROLOGIC EXAMINATION; PHENOTYPE; SENSATION; SEVERITY OF ILLNESS INDEX; SKIN; SURVEYS AND QUESTIONNAIRES;

EID: 84964792417     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000491     Document Type: Article

References (55)

1. Abbott CA, Malik RA, van Ross ERE, Kulkarni J, Boulton AJM. Prevalence and characteristics of painful diabetic neuropathy in a large communitybased diabetic population in the U.K. Diabetes Care 2011; 34: 2220-4
2. Baron R, Förster M, Binder A. Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol 2012; 11: 999-1005
3. Bastien C, Vallières A, Morin C. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001; 2: 297-307
4. Bennett M. The LANSS Pain Scale: the leeds assessment of neuropathic symptoms and signs. PAIN 2001; 92: 147-57
5. Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, EberhardtM, SchnölzerM, Lasitschka F, Lasischka F, NeuhuberWL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Humpert PM, Schwaninger M, Ziegler D, Stern DM, Cooper ME, Haberkorn U, Brownlee M, Reeh PW, Nawroth PP. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012; 18: 926-33
6. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri- Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). PAIN 2005; 114: 29-36
7. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of theNeuropathic Pain SymptomInventory.PAIN2004; 108: 248-57
8. Bouhassira D, Letanoux M, Hartemann A. Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PLoS One 2013; 8: e74195
9. Bouhassira D, Wilhelm S, Schacht A, Perrot S, Kosek E, Cruccu G, Freynhagen R, Tesfaye S, LledóA, Choy E, Marchettini P, MicóJA, Spaeth M, Skljarevski V, Tölle T. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study. PAIN 2014; 155: 2171-9
10. Bril V, Perkins BA. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care 2002; 25: 2048-52
11. Buschbacher R, Orahlow N. Manual of nerve conduction studies: Demos Medical Publishing, New York, 2006
12. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-34
13. Cashman CR, Höke A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett 2015; 596: 33-50
14. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470
15. Cheng HT, Dauch JR, Porzio MT, Yanik BM, Hsieh W, Smith AG, Singleton JR, Feldman EL. Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. J Pain 2013; 14: 941-7
16. Demant DT, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup NB, Jensen TS, Sindrup SH. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebocontrolled phenotype-stratified study. PAIN 2014; 155: 2263-73
17. Dermanovic Dobrota V, HrabacP, SkegroD, Smiljanic R, Dobrota S, Prkacin I, Brkljacic N, Peros K, Tomic M, Lukinovic-Skudar V, Basic Kes V. The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes 2014; 12: 171
18. Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. PAIN 2012; 153: 1148-58
19. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of ElectrodiagnosticMedicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64: 199-207
20. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 1998; 5: 209-27
21. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, HaanpääM, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice ASC, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-Analysis. Lancet Neurol 2015; 14: 162-73
22. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-20
23. Hedges B, di Salvo P. Alcohol consumption and smoking. In: Prescott- Clarke P, Primatesta P, editors. Joint Health Surveys Unit of Social and Community Planning Research and University College London. (2010). Health Survey for England, 1996. [data collection]. 4th Edition. UK Data Service. SN: 3886. p. 305-20
24. Jain R, Jain S, Raison CL, Maletic V. Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators. Curr Diab Rep 2011; 11: 275-84
25. Jensen TS, Bach FW, Kastrup J, Deigaard A, Brennum J. Vibratory and thermal thresholds in diabetics with and without clinical neuropathy. Acta Neurol Scand 1991; 84: 326-33
26. Jensen TS, Baron R, HaanpääM, Kalso E, Loeser JD, Rice ASC, Treede RD. A new definition of neuropathic pain. PAIN 2011; 152: 2204-5
27. Kleyweg RP, van Der MechéFG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain- Barrésyndrome. Muscle Nerve 1991; 14: 1103-9
28. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith A, Hsieh S, Mellgren S, Umapathi T, Ziegler D, Faber C, Merkies I. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15: 202-7
29. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies ISJ, Polydefkis M, Smith AG, Sommer C, Valls-SoléJ. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17: 79-92
30. Lauria G, Ziegler D, Malik R, Merkies IS, Waxman SG, Faber CG. The role of sodium channels in painful diabetic and idiopathic neuropathy. Curr Diab Rep 2014; 14: 538
31. MagerlW, Krumova EK, Baron R, Tölle T, Treede R-D, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. PAIN 2010; 151: 598-605
32. Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F, Gierthmühlen J, Flor H, Geber C, Huge V, Krumova EK, Landwehrmeyer GB, Magerl W, Maihöfner C, Richter H, Rolke R, Scherens A, Schwarz A, Sommer C, Tronnier V, Uçeyler N, ValetM, WasnerG, Treede RDD. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. PAIN 2010; 150: 439-50
33. McCracken L, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): preliminary development and validity. Pain Res Manag 2002; 7: 45-50
34. Medical Research Council-Nerve Injuries Research Committee. Aids to the examination of the peripheral nervous system: Saunders Elsevier, Philadelphia, PA, on behalf of Guarantors of Brain, 2010
35. Osman A, Barrios F, Kopper B, Hauptmann W, Jones J, ONeill E. Factor structure, reliability, and validity of the pain catastrophizing scale. J Behav Med 1997; 20: 589-605
36. Phillips T, Brown M, Ramirez J, Perkins J, Woldeamanuel Y, Williams A, Orengo C, Bennett D, Bodi I, Cox S, Maier C, Krumova E, Rice A. Sensory, psychological, and metabolic dysfunction in HIV-Associated peripheral neuropathy: a cross-sectional deep profiling study. PAIN2014; 155: 1846-60
37. Pincus T, Williams A, Vogel S, Field A. The development and testing of the depression, anxiety, and positive outlook scale (DAPOS). PAIN 2004; 109: 181-8
38. Rolke R, Baron R, Maier C, Tölle TR, Treede RDD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. PAIN 2006; 123: 231-43
39. Rolke R, Magerl W, Campbell K, Schalber C, Caspari S, Birklein F, Treede R. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006; 10: 77-88
40. Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, Hsieh ST. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004; 127(pt 7): 1593-605
41. Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-De Cruz E, Glue P, Whalen E, Emir B, Scott GN, Freeman R; Group ObotHNS. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebocontrolled trial. Neurology 2010; 74: 413-20
42. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883-7
43. Spallone V, Morganti R, DAmato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 2012; 29: 578-85
44. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 2004; 5: 133-7
45. Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 2013; 36: 2456-65
46. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-93
47. Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJM. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011; 27: 629-38
48. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-5
49. Truini A, Biasiotta A, Di Stefano G, Leone C, La Cesa S, Galosi E, Piroso S, Pepe A, Giordano C, Cruccu G. Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain?. PAIN 2014; 155: 828-32
50. Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, Mathieu C, Colin IM. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009; 35: 206-13
51. Von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012; 73: 638-52
52. Ware J, Sherbourne C. TheMOS 36-itemshort-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83
53. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-4
54. Zilliox L, Peltier AC, Wren PA, Anderson A, Smith AG, Singleton JR, Feldman EL, Alexander NB, Russell JW. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 2011; 76: 1099-105
55. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014; 2: 56-64